The ERSPC Quality Control Committee.

Suppr

超能文献

作者信息

Ciatto S

机构信息

Department of Diagnostic Medical Imaging, CSPO, Firenze, Italy.

出版信息

BJU Int. 2003 Dec;92 Suppl 2:57-61. doi: 10.1111/j.1465-5101.2003.04399.x.

DOI:10.1111/j.1465-5101.2003.04399.x

PMID:14983957

Abstract

摘要

相似文献

The ERSPC Quality Control Committee.

BJU Int. 2003 Dec;92 Suppl 2:57-61. doi: 10.1111/j.1465-5101.2003.04399.x.

Monitoring the ERSPC trial.

BJU Int. 2003 Dec;92 Suppl 2:112-4. doi: 10.1111/j.1464-410x.2003.4410x.x.

Contamination by opportunistic screening in the European Randomized Study of Prostate Cancer Screening.

BJU Int. 2003 Dec;92 Suppl 2:97-100. doi: 10.1111/j.1464-410x.2003.04407.x.

The Data Monitoring Committee--bridging the gap between urology and public health epidemiology.

BJU Int. 2003 Dec;92 Suppl 2:55-6. doi: 10.1111/j.1465-5101.2003.04398.x.

The ERSPC Study: Quality Takes Time and Perseverance.

Clin Chem. 2019 Jan;65(1):208-209. doi: 10.1373/clinchem.2018.287110. Epub 2018 Nov 20.

Quality assessment for prostate-specific antigen (PSA) in relation to ERSPC: report of the PSA committee.

BJU Int. 2003 Dec;92 Suppl 2:66-70. doi: 10.1111/j.1465-5101.2003.04401.x.

Screening for prostate cancer: practical analysis of the ERSPC [corrected] and PLCO trials.

Eur Urol. 2011 Mar;59(3):365-9. doi: 10.1016/j.eururo.2010.11.032. Epub 2010 Dec 1.

Detection of prostate cancer: the impact of the European Randomized Study of Screening for Prostate Cancer (ERSPC).

Can J Urol. 2005 Feb;12 Suppl 1:2-6; discussion 92-3.

Branding the ERSPC: a waste or a need?

BJU Int. 2003 Dec;92 Suppl 2:115-6. doi: 10.1111/j.1464-410x.2003.4411x.x.

Prostate cancer: to screen or not to screen?

Nat Rev Urol. 2009 Jun;6(6):299-301. doi: 10.1038/nrurol.2009.92.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

The ERSPC Quality Control Committee.

BJU Int. 2003 Dec;92 Suppl 2:57-61. doi: 10.1111/j.1465-5101.2003.04399.x.

Monitoring the ERSPC trial.

BJU Int. 2003 Dec;92 Suppl 2:112-4. doi: 10.1111/j.1464-410x.2003.4410x.x.

Contamination by opportunistic screening in the European Randomized Study of Prostate Cancer Screening.

BJU Int. 2003 Dec;92 Suppl 2:97-100. doi: 10.1111/j.1464-410x.2003.04407.x.

The Data Monitoring Committee--bridging the gap between urology and public health epidemiology.

BJU Int. 2003 Dec;92 Suppl 2:55-6. doi: 10.1111/j.1465-5101.2003.04398.x.

The ERSPC Study: Quality Takes Time and Perseverance.

Clin Chem. 2019 Jan;65(1):208-209. doi: 10.1373/clinchem.2018.287110. Epub 2018 Nov 20.

Quality assessment for prostate-specific antigen (PSA) in relation to ERSPC: report of the PSA committee.

BJU Int. 2003 Dec;92 Suppl 2:66-70. doi: 10.1111/j.1465-5101.2003.04401.x.

Screening for prostate cancer: practical analysis of the ERSPC [corrected] and PLCO trials.

Eur Urol. 2011 Mar;59(3):365-9. doi: 10.1016/j.eururo.2010.11.032. Epub 2010 Dec 1.

Detection of prostate cancer: the impact of the European Randomized Study of Screening for Prostate Cancer (ERSPC).

Can J Urol. 2005 Feb;12 Suppl 1:2-6; discussion 92-3.

Branding the ERSPC: a waste or a need?

BJU Int. 2003 Dec;92 Suppl 2:115-6. doi: 10.1111/j.1464-410x.2003.4411x.x.

Prostate cancer: to screen or not to screen?

Nat Rev Urol. 2009 Jun;6(6):299-301. doi: 10.1038/nrurol.2009.92.